Release Date: 27/11/13 18:04 Summary: Business Update - Acquisition and Guidance Upgrade Price Sensitive: Yes Download Document 211.9KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%